Immunicum AB: Immunicum AB (publ) Announces ATMP Certificate Granted by EMA to Ilixadencel for Manufacturing Quality and Non-clinical Data

What we doOur approachPipelineTechnology
About usManagementBoardClinical Advisory BoardCareers
NewsroomPress ReleasesEventsPatient Stories
Investors

Back
Immunicum AB: Immunicum AB (publ) Announces ATMP Certificate Granted by EMA to Ilixadencel for Manufacturing Quality and Non-clinical Data
 8:00:05 AM

Keep reading
Immunicum reports positive phase I/II-data for the therapeutic cancer vaccine INTUVAX® in the treatment of kidney cancerRead